Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy

BACKGROUND: Nasopharyngeal carcinoma (NPC), especially the nonkeratinizing type, is a malignant tumor primarily occurring in southern China and Southeast Asia. Chemotherapy (CT) and combined radiotherapy (RT) is used to treat NPC. However, the mortality rate is high in recurrent and metastatic NPC....

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ling, Xu, Shengen, Li, Xiaochen, Sun, Xingwang, Long, Wenbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940331/
https://www.ncbi.nlm.nih.gov/pubmed/36803974
http://dx.doi.org/10.1186/s12885-023-10629-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940331/
https://www.ncbi.nlm.nih.gov/pubmed/36803974
http://dx.doi.org/10.1186/s12885-023-10629-4

Ejemplares similares